Navigation Links
Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
Date:4/3/2008

CHARENTON-LE-PONT, France, April 4 /PRNewswire-FirstCall/ -- Essilor is pursuing its external growth strategy in Italy and the United States.

The Group has stepped up its development in Italy with the acquisition of Galileo, a major player in the Italian market. The company sells prescription and stock lenses under its own brand, which is widely recognized in the optics industry and among Italian consumers. Galileo operates a prescription laboratory in Milan and generates EUR13 million in annual revenue.

Essilor of America, a subsidiary of Essilor International, has strengthened its prescription laboratory network in the United States with the acquisition of a majority stake in Empire Optical of California, Inc., located in North Hollywood. A distributor of Varilux(R) lenses, the company has 168 employees and US$23 million in full-year revenue. Empire has major potential for developing Essilor lenses and enables the Group to increase its market share in the nation's most populous state.

Lastly, Essilor of America has also acquired a majority stake in two prescription laboratories: Advance Optical Sales Co., Inc. in Rochester, New York, with revenue of US$6.1 million, and Future Optics Inc. in Jackson, Tennessee, with revenue of US$3.3 million.

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 270 lens finishing laboratories and local distribution networks. The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index. Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF:FP

Investor Relations and Financial Communications

Veronique Gillet - Sebastien Leroy

Phone: +33-1-49-77-42-16

http://www.essilor.com


'/>"/>
SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Essilor : 2007 Results
2. Essilor Enters Bulgarian Market
3. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
4. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
5. PolyRemedy Strengthens Executive Team With Additions of Diane Cooper, PhD, and Joe Coyne
6. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
7. DuPont Strengthens Leading Biotechnology Position with Leadership Changes
8. Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase
9. ESFs EMRC strengthens training course on clinical trials management
10. HEALTHeCAREERS Network Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. Heraeus Strengthens Medical Components Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
Breaking Medicine Technology: